.png)
Vaccines & Vaccination Market by Type and Application - Global Industry Analysis & Forecast to 2027
Published On : November 2019 Pages : 158 Category: Medical Devices Report Code : HC117100
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Vaccines & Vaccination Market By Type (Subunit vaccines, Live attenuated vaccines, Conjugate vaccines) and Application (Pediatrics disease, Adults disease) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Vaccines & Vaccination Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Market development is credited to the high consumption of irresistible illnesses, developing help for antibody R&D, speculations into immunization advancement, and a rising spotlight on vaccination. Vaccine improvement is a capital-concentrated technique. The advancement procedure (from in vitro research to showcasing) takes 10–15 years and a venture of USD million–USD billion. In addition, as the achievement pace of immunization improvement is exceptionally low, makers think that its difficult to get introductory speculations and oversee operational expenses.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Vaccines & Vaccination Market size market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Pediatrics disease
- Adults disease
- Abbott
- AstraZeneca
- Bavarian Nordic
- Novartis
- Bharat Biotech
- Bio-Med
- CSL
- Emergent BioSolutions
- GSK
- Johnson & Johnson
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Vaccines & Vaccination Market , By Type, Estimates and Forecast, 2017-2027 ($Million)
o Subunit vaccines
o Live attenuated vaccines
o Conjugate vaccines
· Vaccines & Vaccination Market , By Application, Estimates and Forecast, 2017-2027 ($Million)
o Pediatrics disease
o Adults disease
· Vaccines & Vaccination Market , By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Pediatrics disease
o Adults disease
o Abbott
o AstraZeneca
o Bavarian Nordic
o Novartis
o Bharat Biotech
o Bio-Med
o CSL
o Emergent BioSolutions
o GSK
o Johnson & Johnson
· Vaccines & Vaccination Market , By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Vaccines & Vaccination Market , By Country
o U.S. Vaccines & Vaccination Market
o Canada Vaccines & Vaccination Market
o Mexico Vaccines & Vaccination Market
o Europe
§ Europe Vaccines & Vaccination Market , By Country
· Germany Vaccines & Vaccination Market
o UK Vaccines & Vaccination Market
o France Vaccines & Vaccination Market
o Russia Vaccines & Vaccination Market
o Italy Vaccines & Vaccination Market
o Rest of Europe Vaccines & Vaccination Market
o Asia-Pacific
§ Asia-Pacific Vaccines & Vaccination Market , By Country
o China Vaccines & Vaccination Market
o Japan Vaccines & Vaccination Market
o South Korea Vaccines & Vaccination Market
o India Vaccines & Vaccination Market
o Southeast Asia Vaccines & Vaccination Market
o Rest of Asia-Pacific Vaccines & Vaccination Market
o South America
§ South America Vaccines & Vaccination Market
o Brazil Vaccines & Vaccination Market
o Argentina Vaccines & Vaccination Market
o Columbia Vaccines & Vaccination Market
o Rest of South America Vaccines & Vaccination Market
o Middle East and Africa
§ Middle East and Africa Vaccines & Vaccination Market
o Saudi Arabia Vaccines & Vaccination Market
o UAE Vaccines & Vaccination Market
o Egypt Vaccines & Vaccination Market
o Nigeria Vaccines & Vaccination Market
o South Africa Vaccines & Vaccination Market
o Rest of MEA Vaccines & Vaccination Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Market Dashboard
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Vaccines And Vaccination Market, By Type
5.1. Introduction
5.2. Global Vaccines And Vaccination Revenue and Market Share by Type (2017-2027)
5.2.1. Global Vaccines And Vaccination Revenue and Revenue Share by Type (2017-2027)
5.3. Subunit vaccines
5.3.1. Global Subunit vaccines Revenue and Growth Rate (2017-2027)
5.4. Live attenuated vaccines
5.4.1. Global Live attenuated vaccines Revenue and Growth Rate (2017-2027)
5.5. Conjugate vaccines
5.5.1. Global Conjugate vaccines Revenue and Growth Rate (2017-2027)
6. Vaccines And Vaccination Market, By Application
6.1. Introduction
6.2. Global Vaccines And Vaccination Revenue and Market Share by Application (2017-2027)
6.2.1. Global Vaccines And Vaccination Revenue and Revenue Share by Application (2017-2027)
6.3. Pediatrics disease
6.3.1. Global Pediatrics disease Revenue and Growth Rate (2017-2027)
6.4. Adults disease
6.4.1. Global Adults disease Revenue and Growth Rate (2017-2027)
7. Vaccines And Vaccination Market, By Region
7.1. Introduction
7.2. Global Vaccines And Vaccination Revenue and Market Share by Regions
7.2.1. Global Vaccines And Vaccination Revenue by Regions (2017-2027)
7.3. North America Vaccines And Vaccination by Countries
7.3.1. North America Vaccines And Vaccination Revenue and Growth Rate (2017-2027)
7.3.2. North America Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Vaccines And Vaccination by Countries
7.4.1. Europe Vaccines And Vaccination Revenue and Growth Rate (2017-2027)
7.4.2. Europe Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Vaccines And Vaccination by Countries
7.5.1. Asia-Pacific Vaccines And Vaccination Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Vaccines And Vaccination by Countries
7.6.1. South America Vaccines And Vaccination Revenue and Growth Rate (2017-2027)
7.6.2. South America Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Vaccines And Vaccination by Countries
7.7.1. Middle East and Africa Vaccines And Vaccination Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Abbott
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. AstraZeneca
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Bavarian Nordic
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Novartis
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Bharat Biotech
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Bio-Med
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. CSL
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Emergent BioSolutions
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. GSK
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Johnson & Johnson
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
9. Vaccines And Vaccination Market Forecast (2017-2027)
9.1. Global Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Vaccines And Vaccination Market Forecast by Regions (2017-2027)
9.2.1. North America Vaccines And Vaccination Market Forecast (2017-2027)
9.2.1.1. United States Vaccines And Vaccination Market Forecast (2017-2027)
9.2.1.2. Canada Vaccines And Vaccination Market Forecast (2017-2027)
9.2.1.3. Mexico Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2. Europe Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.1. Germany Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.2. France Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.3. UK Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.4. Russia Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.5. Italy Vaccines And Vaccination Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3. Asia-Pacific Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.1. China Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.2. Japan Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.3. Korea Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.4. India Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Vaccines And Vaccination Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Vaccines And Vaccination Market Forecast (2017-2027)
9.2.4. South America Vaccines And Vaccination Market Forecast (2017-2027)
9.2.4.1. Brazil Vaccines And Vaccination Market Forecast (2017-2027)
9.2.4.2. Argentina Vaccines And Vaccination Market Forecast (2017-2027)
9.2.4.3. Columbia Vaccines And Vaccination Market Forecast (2017-2027)
9.2.4.4. Rest of South America Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5. Middle East and Africa Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.3. Egypt Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.4. Nigeria Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.5. South Africa Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.6. Turkey Vaccines And Vaccination Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Vaccines And Vaccination Market Forecast (2017-2027)
9.3. Vaccines And Vaccination Market Forecast by Type (2017-2027)
9.3.1. Vaccines And Vaccination Forecast by Type (2017-2027)
9.3.2. Vaccines And Vaccination Market Share Forecast by Type (2017-2027)
9.4. Vaccines And Vaccination Market Forecast by Application (2017-2027)
9.4.1. Vaccines And Vaccination Forecast by Application (2017-2027)
9.4.2. Vaccines And Vaccination Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Vaccines And Vaccination Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Vaccines And Vaccination Revenue and Revenue Share by Type (2017-2018)
Figure Global Subunit vaccines Revenue and Growth Rate (2017-2018)
Figure Global Live attenuated vaccines Revenue and Growth Rate (2017-2018)
Figure Global Conjugate vaccines Revenue and Growth Rate (2017-2018)
Table Global Vaccines And Vaccination Revenue and Revenue Share by Application (2017-2018)
Figure Global Pediatrics disease Revenue and Growth Rate (2017-2018)
Figure Global Adults disease Revenue and Growth Rate (2017-2018)
Table Global Vaccines And Vaccination Revenue by Regions (2017-2018)
Figure North America Vaccines And Vaccination Growth Rate (2017-2018)
Figure North America Vaccines And Vaccination Revenue and Growth Rate (2017-2018)
Figure North America Vaccines And Vaccination by Countries (2017-2018)
Figure North America Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2018)
Figure United States Vaccines And Vaccination Growth Rate (2017-2018)
Figure United States Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Vaccines And Vaccination Growth Rate (2017-2018)
Figure Canada Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Vaccines And Vaccination Growth Rate (2017-2018)
Figure Mexico Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Vaccines And Vaccination Growth Rate (2017-2018)
Figure Europe Vaccines And Vaccination Revenue and Growth Rate (2017-2018)
Figure Europe Vaccines And Vaccination by Countries (2017-2018)
Figure Europe Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2018)
Figure Germany Vaccines And Vaccination Growth Rate (2017-2018)
Figure Germany Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Vaccines And Vaccination Growth Rate (2017-2018)
Figure France Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Vaccines And Vaccination Growth Rate (2017-2018)
Figure UK Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Vaccines And Vaccination Growth Rate (2017-2018)
Figure Russia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Vaccines And Vaccination Growth Rate (2017-2018)
Figure Italy Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Vaccines And Vaccination Growth Rate (2017-2018)
Figure Rest of Europe Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Vaccines And Vaccination Growth Rate (2017-2018)
Figure Asia-Pacific Vaccines And Vaccination Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Vaccines And Vaccination by Countries (2017-2018)
Figure Asia-Pacific Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2018)
Figure China Vaccines And Vaccination Growth Rate (2017-2018)
Figure China Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Vaccines And Vaccination Growth Rate (2017-2018)
Figure Japan Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Vaccines And Vaccination Growth Rate (2017-2018)
Figure Korea Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Vaccines And Vaccination Growth Rate (2017-2018)
Figure India Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Vaccines And Vaccination Growth Rate (2017-2018)
Figure Southeast Asia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Vaccines And Vaccination Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Vaccines And Vaccination Growth Rate (2017-2018)
Figure South America Vaccines And Vaccination Revenue and Growth Rate (2017-2018)
Figure South America Vaccines And Vaccination by Countries (2017-2018)
Figure South America Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Vaccines And Vaccination Growth Rate (2017-2018)
Figure Brazil Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Vaccines And Vaccination Growth Rate (2017-2018)
Figure Argentina Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Vaccines And Vaccination Growth Rate (2017-2018)
Figure Columbia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Vaccines And Vaccination Growth Rate (2017-2018)
Figure Rest of South America Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Vaccines And Vaccination Growth Rate (2017-2018)
Figure Middle East and Africa Vaccines And Vaccination Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Vaccines And Vaccination by Countries (2017-2018)
Figure Middle East and Africa Vaccines And Vaccination Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Vaccines And Vaccination Growth Rate (2017-2018)
Figure Saudi Arabia Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Vaccines And Vaccination Growth Rate (2017-2018)
Figure United Arab Emirates Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Vaccines And Vaccination Growth Rate (2017-2018)
Figure Egypt Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Vaccines And Vaccination Growth Rate (2017-2018)
Figure Nigeria Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Vaccines And Vaccination Growth Rate (2017-2018)
Figure South Africa Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Vaccines And Vaccination Growth Rate (2017-2018)
Figure Turkey Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Vaccines And Vaccination Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2017-2018)
Table Abbott Vaccines And Vaccination Financial Overview
Table AstraZeneca Vaccines And Vaccination Financial Overview
Table Bavarian Nordic Vaccines And Vaccination Financial Overview
Table Novartis Vaccines And Vaccination Financial Overview
Table Bharat Biotech Vaccines And Vaccination Financial Overview
Table Bio-Med Vaccines And Vaccination Financial Overview
Table CSL Vaccines And Vaccination Financial Overview
Table Emergent BioSolutions Vaccines And Vaccination Financial Overview
Table GSK Vaccines And Vaccination Financial Overview
Table Johnson & Johnson Vaccines And Vaccination Financial Overview
Figure Global Vaccines And Vaccination Revenue (Millions USD) and Growth Rate (2018-2025)
Table Vaccines And Vaccination Market Forecast by Regions (2018-2025)
Figure North America Vaccines And Vaccination Market Forecast (2018-2025)
Figure United States Vaccines And Vaccination Market Forecast (2018-2025)
Figure Canada Vaccines And Vaccination Market Forecast (2018-2025)
Figure Mexico Vaccines And Vaccination Market Forecast (2018-2025)
Figure Europe Vaccines And Vaccination Market Forecast (2018-2025)
Figure Germany Vaccines And Vaccination Market Forecast (2018-2025)
Figure France Vaccines And Vaccination Market Forecast (2018-2025)
Figure UK Vaccines And Vaccination Market Forecast (2018-2025)
Figure Russia Vaccines And Vaccination Market Forecast (2018-2025)
Figure Italy Vaccines And Vaccination Market Forecast (2018-2025)
Figure Rest of Europe Vaccines And Vaccination Market Forecast (2018-2025)
Figure Asia-Pacific Vaccines And Vaccination Market Forecast (2018-2025)
Figure China Vaccines And Vaccination Market Forecast (2018-2025)
Figure Japan Vaccines And Vaccination Market Forecast (2018-2025)
Figure Korea Vaccines And Vaccination Market Forecast (2018-2025)
Figure India Vaccines And Vaccination Market Forecast (2018-2025)
Figure Southeast Asia Vaccines And Vaccination Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Vaccines And Vaccination Market Forecast (2018-2025)
Figure South America Vaccines And Vaccination Market Forecast (2018-2025)
Figure Brazil Vaccines And Vaccination Market Forecast (2018-2025)
Figure Argentina Vaccines And Vaccination Market Forecast (2018-2025)
Figure Columbia Vaccines And Vaccination Market Forecast (2018-2025)
Figure Rest of South America Vaccines And Vaccination Market Forecast (2018-2025)
Figure Middle East and Africa Vaccines And Vaccination Market Forecast (2018-2025)
Figure Saudi Arabia Vaccines And Vaccination Market Forecast (2018-2025)
Figure United Arab Emirates Vaccines And Vaccination Market Forecast (2018-2025)
Figure Egypt Vaccines And Vaccination Market Forecast (2018-2025)
Figure Nigeria Vaccines And Vaccination Market Forecast (2018-2025)
Figure South Africa Vaccines And Vaccination Market Forecast (2018-2025)
Figure Turkey Vaccines And Vaccination Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Vaccines And Vaccination Market Forecast (2018-2025)
Figure Global Vaccines And Vaccination Forecast by Type (2018-2025)
Figure Global Vaccines And Vaccination Market Share Forecast by Type (2018-2025)
Figure Global Vaccines And Vaccination Forecast by Type (2018-2025)
Figure Global Vaccines And Vaccination Forecast by Application (2018-2025)
Figure Global Vaccines And Vaccination Market Share Forecast by Application (2018-2025)
Figure Global Vaccines And Vaccination Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|